4
Changes in Ownership
AEON Biopharma, Inc. Filed Acc 0001104659-23-083566
Options or other derivatives
- Chief Executive Officer acquired 2,441,394 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Forth Marc · Chief Executive Officer
Table II: Derivative
6 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-07-21 | Grant or award : show line 1 in the form Stock Option | +970,588 | 970,588 | D |
| 2023-07-21 | Grant or award : show line 2 in the form Stock Option | +324,021 | 324,021 | D |
| 2023-07-21 | Grant or award : show line 3 in the form Stock Option | +291,332 | 291,332 | D |
| 2023-07-21 | Grant or award : show line 4 in the form Stock Option | +381,480 | 381,480 | D |
| 2023-07-21 | Grant or award : show line 5 in the form Stock Option | +194,118 | 194,118 | D |
| 2023-07-21 | Grant or award : show line 6 in the form Restricted Stock Units | +279,855 | 279,855 | D |
Loading xslF345X05/tm2321918-9_4seq1.xml…